Quantum-Si incorporated (QSI)

NASDAQ: QSI · Real-Time Price · USD
1.300
+0.010 (0.78%)
At close: Dec 20, 2024, 4:00 PM
1.310
+0.010 (0.77%)
After-hours: Dec 20, 2024, 7:59 PM EST
0.78%
Market Cap 185.53M
Revenue (ttm) 2.27M
Net Income (ttm) -89.93M
Shares Out 142.71M
EPS (ttm) -0.63
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 13,110,177
Open 1.240
Previous Close 1.290
Day's Range 1.200 - 1.340
52-Week Range 0.612 - 2.580
Beta 3.23
Analysts Buy
Price Target 3.25 (+150.0%)
Earnings Date Nov 12, 2024

About QSI

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company’s platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; Proteus, transforming proteomic research; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applic... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2013
Employees 159
Stock Exchange NASDAQ
Ticker Symbol QSI
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for QSI stock is "Buy." The 12-month stock price forecast is $3.25, which is an increase of 150.00% from the latest price.

Price Target
$3.25
(150.00% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Quantum-Si's New Preprint Showcases Advances in Protein Variant Detection using ProteoVue™ Software with Next-Generation Protein Sequencing™

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a new paper that was submitted to BioRx...

1 day ago - Business Wire

Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4).

3 days ago - Business Wire

Quantum-Si Expands International Distribution Network

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Expands International Distribution Network.

9 days ago - Business Wire

Quantum-Si Launches Platinum® New Library Prep Kit, Expanding Access to Next-Generation Protein Sequencing™

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Launches Platinum® New Library Prep Kit, Expanding Access to Next-Generation Protein Sequencing™.

17 days ago - Business Wire

Quantum-Si Introduces Protein Barcoding Kit for Multiplexed Protein Screening

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Introduces Protein Barcoding Kit for Multiplexed Protein Screening.

18 days ago - Business Wire

Quantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor & Analyst Event

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the highlights of an Investor & Analyst...

4 weeks ago - Business Wire

Nvidia Partners With Quantum-Si To Advance Single-Molecule Analysis

On Wednesday, Quantum-Si Incorporated QSI stock traded over 100% higher after the protein sequencing company announced a collaboration with NVIDIA Corporation NVDA to develop its new proteomics platfo...

Other symbols: NVDA
4 weeks ago - Benzinga

Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing™ Technology

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has announced a distribution agreement with Avantor® (N...

Other symbols: AVTR
4 weeks ago - Business Wire

Quantum-Si to Develop Acceleration Platform and Advance Core Technologies in Collaboration with NVIDIA

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a collaboration with NVIDIA to develop ...

4 weeks ago - Business Wire

Quantum-Si Expands Collaboration with SkyWater to Develop New Chip Production Process Critical for Groundbreaking New Proteomics Platform

BRANFORD, Conn. & BLOOMINGTON, Minn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™ and SkyWaterTechnology (NASDAQ: SKY...

Other symbols: SKYT
4 weeks ago - Business Wire

Quantum-Si and Planet Innovation to Partner on Proteus™

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, and Planet Innovation today announced that they will pa...

4 weeks ago - Business Wire

Quantum-Si Honored with Frost & Sullivan's 2024 Technology Innovation Leadership Award for Next-Generation Protein Sequencing™

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it has been awarded Frost & Sulliv...

5 weeks ago - Business Wire

Quantum-Si incorporated (QSI) Q3 2024 Earnings Call Transcript

Quantum-Si incorporated (NASDAQ:QSI) Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ET Company Participants Doug Farrell - VP, IR Jeffrey Hawkins - President & CEO Jeffry Keyes - CFO Conf...

5 weeks ago - Seeking Alpha

Quantum-Si Reports Third Quarter 2024 Financial Results

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the third quarter...

5 weeks ago - Business Wire

University of Virginia Researchers Publish New Study on Tropomyosin Proteoforms Showcasing Quantum-Si's Next-Gen Protein Sequencer™ Platinum®

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a newly released preprint publication o...

6 weeks ago - Business Wire

Quantum-Si to Participate in Upcoming Investment Conferences

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will be participating in two up...

6 weeks ago - Business Wire

Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Company will host an Investor ...

7 weeks ago - Business Wire

Quantum-Si to Present at the 2024 American Society of Human Genetics Annual Meeting

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced its attendance at the 2024 American Soc...

7 weeks ago - Business Wire

Quantum-Si to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

BRANFORD, Conn.--(BUSINESS WIRE)--QSI to report Q3 2024 Operating Results on 11/12/24.

2 months ago - Business Wire

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BRANFORD, Conn.--(BUSINESS WIRE)--QSI announces inducement grants.

2 months ago - Business Wire

Renowned Proteomic Researchers to Present Quantum-Si Data at World HUPO 2024

BRANFORD, Conn.--(BUSINESS WIRE)--Renowned Proteomic Researchers to Present Quantum-Si Data at World HUPO 2024.

2 months ago - Business Wire

Liberate Bio Integrates Quantum-Si's Next-Generation Protein Sequencing™ Platform to Enhance Gene Therapy Development

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that Liberate Bio, a Boston-based biote...

3 months ago - Business Wire

CORRECTING and REPLACING Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si announces promotions and appointment of CCO.

4 months ago - Business Wire

Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si announces promotions and appointment of CCO.

4 months ago - Business Wire